
BioPharm International and D&B Launch Business Marketplace
BioPharm International has joined with Dun & Bradstreet Credibility Corp. to launch the Pharmaceutical Technology and BioPharm International Marketplace.
BioPharm International has joined with Dun & Bradstreet Credibility Corp. to launch the
Advanstar, publisher of pharmaceutical life science publications including BioPharm International, is the first B2B publisher to embrace the online Credibility Review Business Marketplace platform developed by Dun & Bradstreet Credibility Corp.
“We are very excited about this opportunity. Given the high costs of developing eDirectories and continually upgrading and supporting these platforms across a wide array of publications, an alternative that leveraged lower upfront costs and scalability with speed to market was very attractive,” said Advanstar Executive Vice-President, Ron Wall.
According to eMarketer’s latest report, digital spending in pharmaceutical and healthcare marketing is forecasted to grow 57% to $2.48 billion by 2016. “Our vision is to create the largest and most dynamic communities of buyers and suppliers with Dun & Bradstreet Credibility Corp., so we can take full advantage of this spending growth,” said Wall.
According to Jeff Stibel, Chairman and CEO, Dun & Bradstreet Credibility Corp., “what we offer is a highly respected and branded platform with enhanced credibility data and information from our database, world class development expertise that will allow all of the Marketplace sites to benefit from ongoing upgrades and enhancements and a seamless integration of social media.”
The new Pharmaceutical Technology/BioPharm International Marketplace will concentrate on business information and news on companies in analytical/lab equipment, contract services, manufacturing equipment, packaging equipment/supplies, pharm/biopharm ingredients, and process control/IT.
Advanstar Life Sciences group will launch additional eDirectories supported by their other publications on the Dun & Bradstreet Credibility Review Marketplace in the coming months.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.